Change region or lenguage
Nurse in blue scrubs operating a device.

CardioSignal

By CardioSignal

Support atrial fibrillation detection in routine care with a 1-minute measurement.

This page at a glance

Product description
CardioSignal is a CE-marked Class IIb medical device designed to detect signs of atrial fibrillation in adults aged 18 years and older. It uses motion sensors to analyze heart motion data during a 1-minute measurement.
Primary value
CardioSignal supports earlier identification of signs of atrial fibrillation and timely medical follow-up. Findings suggestive of atrial fibrillation require confirmation by a healthcare professional.
Who is it for?
Healthcare professionals seeking to incorporate screening for signs of atrial fibrillation into routine care using the cobas® pulse device.
Key capabilities
  • 1-minute measurement
  • Atrial fibrillation screening
  • Clear results
  • Integrated screening: available on cobas pulse
Overview

Detection of signs of atrial fibrillation, integrated with cobas pulse

CardioSignal is available on the cobas pulse system.

CardioSignal adds atrial fibrillation screening capabilities to the cobas pulse device. With a 1-minute measurement, healthcare professionals can detect signs of atrial fibrillation, supporting earlier detection and timely medical follow-up.

Detect signs of atrial fibrillation

Screen for signs of atrial fibrillation with a 1-minute measurement, supporting earlier detection.

Effortless integration

CardioSignal runs directly on the cobas pulse, enabling screening for signs of atrial fibrillation in routine care.

A healthcare worker holding a handheld cobas pulse device displaying an alert for signs of atrial fibrillation.
Features

Detect signs of atrial fibrillation in 1-minute measurement

CardioSignal uses built-in motion sensors (gyroscope and accelerometer) to collect and analyze heart motion data. During a 1-minute measurement, the device is placed on the patient's chest to record subtle movements associated with heart activity. The software analyzes these signals to detect signs of irregular heart rhythm characteristic of atrial fibrillation. Results indicate whether signs of atrial fibrillation were detected, supporting the identification of potential findings that require confirmation by a healthcare professional.

Three cobas pulse devices displaying different screen states: start measurement, no signs of atrial fibrillation, and signs of atrial fibrillation detected.
Benefits

Supporting earlier detection of atrial fibrillation in routine care

CardioSignal enables healthcare professionals to screen for signs of atrial fibrillation using the cobas pulse device. Following a 1-minute measurement, the software provides a result indicating whether signs of atrial fibrillation were detected. By supporting earlier identification of potential atrial fibrillation, CardioSignal can help facilitate timely medical follow-up. Integration with cobas pulse allows healthcare professionals to incorporate screening into routine clinical workflows.

Clinically evaluated atrial fibrillation detection technology

The technology, measurement method and atrial fibrillation detection algorithms underlying CardioSignal have been validated in clinical trials. The clinical trial technology demonstrated 95.3% sensitivity for identifying atrial fibrillation rhythm and 96.0% specificity for identifying sinus rhythm in the study population. The CardioSignal application uses an algorithm derived from the validated clinical trial algorithm, with reported sensitivity and specificity of 94.0% in the study population.¹

Atrial fibrillation
94%sensitivity

Sensitivity for detecting signs of atrial fibrillation in the study population.1

Clinical evaluation
94% specificity

Specificity of the CardioSignal application algorithm in the study population. 1

FAQs

Frequently asked questions about CardioSignal

If you don’t find answers to your questions here, we’re happy to provide more information and discuss your needs in detail.

Explore more

Discover more from our portfolio

CardioSignal

Precordior is a health technology company developing novel solutions for the detection of heart diseases with digital cardiac biomarkers. The CardioSignal application detecting signs of atrial fibrillation is available in 15 countries. The CardioSignal technology utilizes motion sensors to non-invasively measure chest movements and determine cardiac motion and function. Originally an academic spinoff, the company’s patented technology is built on a decade of research and algorithm development.

References and notes
  1. Jaakkola J, et al. Mobile phone detection of atrial fibrillation with mechanocardiography: The MODE-AF study (Mobile Phone Detection of Atrial Fibrillation). Circulation. 2018;137(14):1524-1534. doi:10.1161/CIRCULATIONAHA.117.032804.
Disclaimer
  • Not every digital product is available in all markets. The use of any third-party app is subject to a separate license agreement with the respective third-party app developer. Roche gives no warranties (express or implied) with regard to any third-party app. Third-party apps might not be available in your country. This website and its content may be accessible worldwide, Roche assumes no liability with regard to the access to the information, which may not be compatible with legislations or regulations in force in your country.